Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.03071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Immune Correlates of Postexposure Vaccine Protection Against Marburg Virus

Scientific Reports
Multidisciplinary
2020English

T Cell Activation Depends on Extracellular Alanine

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection Against Lethal Influenza a H5N1 Virus Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

IL-28B Is a Key Regulator of B- And T-Cell Vaccine Responses Against Influenza

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2014English

Activation of Human T Cells by a Tumor Vaccine Infected With Recombinant Newcastle Disease Virus Producing IL-2

International Journal of Oncology
Cancer ResearchOncology
1992English

Designing B- And T-Cell Multi-Epitope Based Subunit Vaccine Using Immunoinformatics Approach to Control Zika Virus Infection

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2018English

A Recombinant Multi-Antigen Vaccine With Broad Protection Potential Against Avian Pathogenic Escherichia Coli

PLoS ONE
Multidisciplinary
2017English

IL-37 Confers Protection Against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation

PLoS ONE
Multidisciplinary
2017English

GB Virus C Infection Is Associated With a Reduced Rate of Reactivation of Latent HIV and Protection Against Activation-Induced T-Cell Death`

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy